Avanos Medical to be Acquired for $25 Per Share in Cash
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 30 2024
0mins
Should l Buy AVNS?
Avanos Medical Inc. has seen a significant price increase of 67.93% in pre-market trading, reaching a 52-week high.
The company has entered into a definitive acquisition agreement with American Industrial Partners, valuing the transaction at approximately $1.272 billion, with shareholders set to receive $25 per share in cash, representing a 72.1% premium over the closing price on April 13. This acquisition reflects strong market confidence in Avanos and is expected to maximize shareholder value while creating new opportunities for employees.
The acquisition is anticipated to close in the second half of 2026, pending shareholder approval and regulatory conditions. This strategic move is expected to enhance Avanos' innovation trajectory and competitive positioning in the medical technology sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVNS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVNS
About AVNS
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes Nexus TKO, an anti-reflux needleless connector technology. The Pain Management and Recovery is a portfolio of non-opioid pain solutions including surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems, as well as Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating Helix Energy Solutions Group, Inc. (NYSE: HLX) for its merger with Hornbeck Offshore Services, Inc., where Helix shareholders will own approximately 45% of the combined company, potentially impacting shareholder rights and future earnings.
- Cash and Stock Options: TopBuild Corp. (NYSE: BLD) is set to be sold to QXO, Inc., allowing shareholders to choose between receiving $505.00 in cash or 20.2 shares of QXO common stock for each TopBuild share, which may influence shareholder returns and decision-making.
- Acquisition Price Confirmation: Avanos Medical, Inc. (NYSE: AVNS) is being sold to affiliates of American Industrial Partners for $25.00 per share in cash, and shareholders need to assess whether this price is fair and its implications for the company's future.
- Shareholder Rights Protection: Affinity Bancshares, Inc. (NASDAQ: AFBI) plans to sell to Fidelity BancShares (N.C.) for $23.00 per share in cash, with the price subject to adjustment based on adjusted stockholders' equity, prompting shareholders to actively understand their legal rights and options.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies including Whitestone REIT, Soleno Therapeutics, Odyssey Marine Exploration, and Avanos Medical for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Whitestone REIT Transaction: Whitestone REIT is being sold to Ares Management Corporation for $19.00 per share, and Halper Sadeh LLC may seek to increase the consideration to ensure shareholders receive fair compensation.
- Soleno Therapeutics Transaction: Soleno Therapeutics, Inc. is being sold for $53.00 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights, potentially requesting additional disclosures to protect shareholder interests.
- Avanos Medical Transaction: Avanos Medical, Inc. is being sold to affiliates of American Industrial Partners for $25.00 per share, and Halper Sadeh LLC may advocate for higher consideration and other remedies for shareholders.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating the sale of Leggett & Platt, Incorporated, where shareholders will receive 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt, resulting in approximately 9% ownership in the combined company, potentially impacting shareholder rights and future earnings.
- Cash Acquisition Details: Avanos Medical, Inc. is being sold to American Industrial Partners for $25.00 per share in cash, prompting shareholders to consider the implications of this transaction on their investments and rights.
- Select Medical Holdings Transaction: Select Medical Holdings Corporation is set to be sold for $16.50 per share in cash to a consortium led by its executives and directors, urging shareholders to understand the potential impacts of this deal and their legal options.
- Merger Transaction Analysis: The merger between Galera Therapeutics, Inc. and Obsidian Therapeutics, Inc. is expected to result in Galera shareholders owning approximately 1.8% of the combined company, necessitating attention to changes in shareholder rights and potential financial impacts post-merger.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Legal Investigation Launched: Halper Sadeh LLC is investigating Leggett & Platt, Incorporated's transaction involving the exchange of 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt, which would result in shareholders owning approximately 9% of the combined company, potentially impacting shareholder rights.
- Cash Acquisition Scrutiny: Avanos Medical, Inc. is under investigation for its sale to American Industrial Partners for $25.00 per share in cash, with Halper Sadeh LLC possibly seeking increased consideration or other compensation to ensure shareholder rights are protected.
- Merger Transaction Review: The merger between McCormick & Company, Incorporated and Unilever's Foods business is also being scrutinized, as McCormick shareholders will own 35% of the combined company post-transaction, prompting Halper Sadeh LLC to request additional disclosures and information to safeguard shareholder interests.
- Investor Rights Advocacy: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, with the firm's efforts potentially recovering millions for defrauded investors, highlighting its crucial role in protecting investor rights.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Avanos Medical, Inc. (NYSE: AVNS) for potential violations of federal securities laws related to its sale to American Industrial Partners for $25.00 per share in cash, raising concerns about fiduciary duties to shareholders.
- Shareholder Rights: Leggett & Platt, Incorporated (NYSE: LEG) is set to sell to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock per Leggett share, resulting in Leggett shareholders owning approximately 9% of the combined entity, with Halper Sadeh LLC encouraging shareholders to explore their rights and options.
- Cash Transaction: Soleno Therapeutics, Inc. (NASDAQ: SLNO) plans to sell to Neurocrine Biosciences for $53.00 per share in cash, prompting Halper Sadeh LLC to remind shareholders of their potential legal rights.
- Management Involvement: Forian Inc. (NASDAQ: FORA) is being sold for $2.17 per share in cash to a consortium led by CEO Max Wygod, with Halper Sadeh LLC potentially seeking increased consideration and other remedies to protect shareholder interests.
See More
Investigations into Multiple Medical Company Mergers
- Avanos Medical Acquisition: Avanos Medical is set to be acquired by American Industrial Partners for $25.00 per share in an all-cash deal valued at approximately $1.272 billion, with investigations focusing on whether the board breached fiduciary duties by failing to ensure a fair process for shareholders.
- Leggett & Platt Merger: Leggett & Platt will be acquired by Somnigroup International in an all-stock transaction valued at around $2.5 billion, where shareholders will receive 0.1455 shares of Somnigroup for each share of Leggett & Platt, raising concerns about potential fiduciary breaches by the board.
- Soleno Therapeutics Acquisition: Soleno is to be acquired by Neurocrine Biosciences for $53.00 per share in cash, representing a total equity value of approximately $2.9 billion, with investigations questioning the fairness of the deal given it is below the company's 52-week high of $90.32.
- Forian, Inc. Investigation: Forian will be acquired by an entity affiliated with CEO Max Wygod for $2.17 per share in cash, with investigations looking into whether the board failed to conduct a fair process, potentially impacting shareholder value.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating Helix Energy Solutions Group, Inc. (NYSE: HLX) for its merger with Hornbeck Offshore Services, Inc., where Helix shareholders will own approximately 45% of the combined company, potentially impacting shareholder rights and future earnings.
- Cash and Stock Options: TopBuild Corp. (NYSE: BLD) is set to be sold to QXO, Inc., allowing shareholders to choose between receiving $505.00 in cash or 20.2 shares of QXO common stock for each TopBuild share, which may influence shareholder returns and decision-making.
- Acquisition Price Confirmation: Avanos Medical, Inc. (NYSE: AVNS) is being sold to affiliates of American Industrial Partners for $25.00 per share in cash, and shareholders need to assess whether this price is fair and its implications for the company's future.
- Shareholder Rights Protection: Affinity Bancshares, Inc. (NASDAQ: AFBI) plans to sell to Fidelity BancShares (N.C.) for $23.00 per share in cash, with the price subject to adjustment based on adjusted stockholders' equity, prompting shareholders to actively understand their legal rights and options.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies including Whitestone REIT, Soleno Therapeutics, Odyssey Marine Exploration, and Avanos Medical for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Whitestone REIT Transaction: Whitestone REIT is being sold to Ares Management Corporation for $19.00 per share, and Halper Sadeh LLC may seek to increase the consideration to ensure shareholders receive fair compensation.
- Soleno Therapeutics Transaction: Soleno Therapeutics, Inc. is being sold for $53.00 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights, potentially requesting additional disclosures to protect shareholder interests.
- Avanos Medical Transaction: Avanos Medical, Inc. is being sold to affiliates of American Industrial Partners for $25.00 per share, and Halper Sadeh LLC may advocate for higher consideration and other remedies for shareholders.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating the sale of Leggett & Platt, Incorporated, where shareholders will receive 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt, resulting in approximately 9% ownership in the combined company, potentially impacting shareholder rights and future earnings.
- Cash Acquisition Details: Avanos Medical, Inc. is being sold to American Industrial Partners for $25.00 per share in cash, prompting shareholders to consider the implications of this transaction on their investments and rights.
- Select Medical Holdings Transaction: Select Medical Holdings Corporation is set to be sold for $16.50 per share in cash to a consortium led by its executives and directors, urging shareholders to understand the potential impacts of this deal and their legal options.
- Merger Transaction Analysis: The merger between Galera Therapeutics, Inc. and Obsidian Therapeutics, Inc. is expected to result in Galera shareholders owning approximately 1.8% of the combined company, necessitating attention to changes in shareholder rights and potential financial impacts post-merger.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Legal Investigation Launched: Halper Sadeh LLC is investigating Leggett & Platt, Incorporated's transaction involving the exchange of 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt, which would result in shareholders owning approximately 9% of the combined company, potentially impacting shareholder rights.
- Cash Acquisition Scrutiny: Avanos Medical, Inc. is under investigation for its sale to American Industrial Partners for $25.00 per share in cash, with Halper Sadeh LLC possibly seeking increased consideration or other compensation to ensure shareholder rights are protected.
- Merger Transaction Review: The merger between McCormick & Company, Incorporated and Unilever's Foods business is also being scrutinized, as McCormick shareholders will own 35% of the combined company post-transaction, prompting Halper Sadeh LLC to request additional disclosures and information to safeguard shareholder interests.
- Investor Rights Advocacy: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, with the firm's efforts potentially recovering millions for defrauded investors, highlighting its crucial role in protecting investor rights.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Avanos Medical, Inc. (NYSE: AVNS) for potential violations of federal securities laws related to its sale to American Industrial Partners for $25.00 per share in cash, raising concerns about fiduciary duties to shareholders.
- Shareholder Rights: Leggett & Platt, Incorporated (NYSE: LEG) is set to sell to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock per Leggett share, resulting in Leggett shareholders owning approximately 9% of the combined entity, with Halper Sadeh LLC encouraging shareholders to explore their rights and options.
- Cash Transaction: Soleno Therapeutics, Inc. (NASDAQ: SLNO) plans to sell to Neurocrine Biosciences for $53.00 per share in cash, prompting Halper Sadeh LLC to remind shareholders of their potential legal rights.
- Management Involvement: Forian Inc. (NASDAQ: FORA) is being sold for $2.17 per share in cash to a consortium led by CEO Max Wygod, with Halper Sadeh LLC potentially seeking increased consideration and other remedies to protect shareholder interests.
See More
Investigations into Multiple Medical Company Mergers
- Avanos Medical Acquisition: Avanos Medical is set to be acquired by American Industrial Partners for $25.00 per share in an all-cash deal valued at approximately $1.272 billion, with investigations focusing on whether the board breached fiduciary duties by failing to ensure a fair process for shareholders.
- Leggett & Platt Merger: Leggett & Platt will be acquired by Somnigroup International in an all-stock transaction valued at around $2.5 billion, where shareholders will receive 0.1455 shares of Somnigroup for each share of Leggett & Platt, raising concerns about potential fiduciary breaches by the board.
- Soleno Therapeutics Acquisition: Soleno is to be acquired by Neurocrine Biosciences for $53.00 per share in cash, representing a total equity value of approximately $2.9 billion, with investigations questioning the fairness of the deal given it is below the company's 52-week high of $90.32.
- Forian, Inc. Investigation: Forian will be acquired by an entity affiliated with CEO Max Wygod for $2.17 per share in cash, with investigations looking into whether the board failed to conduct a fair process, potentially impacting shareholder value.
See More
